Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia
about
Cdx4 and menin co-regulate Hoxa9 expression in hematopoietic cellsThe human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemiaMOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcriptionNew insight into the molecular mechanisms of MLL-associated leukemiaThe MLL fusion gene, MLL-AF4, regulates cyclin-dependent kinase inhibitor CDKN1B (p27kip1) expressionMLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein functionThe elongation domain of ELL is dispensable but its ELL-associated factor 1 interaction domain is essential for MLL-ELL-induced leukemogenesisHoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalizationThe miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expressionRegulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalizationMLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding proteinGenomic profiling of B-progenitor acute lymphoblastic leukemiaAnimal models of leukemia: any closer to the real thing?Structure of the MLL CXXC domain-DNA complex and its functional role in MLL-AF9 leukemia.BET domain co-regulators in obesity, inflammation and cancerGeneration of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia TherapyStructure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis.Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4Transcriptional regulation of BRD7 expression by Sp1 and c-Myc.Intrinsic structural disorder confers cellular viability on oncogenic fusion proteinsTumor-specific and proliferation-specific gene expression typifies murine transgenic B cell lymphomagenesis.E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia.Conditional MLL-CBP targets GMP and models therapy-related myeloproliferative disease.Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.An emerging role for bromodomain-containing proteins in chromatin regulation and transcriptional control of adipogenesis.A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes.MLL-SEPTIN6 fusion recurs in novel translocation of chromosomes 3, X, and 11 in infant acute myelomonocytic leukaemia and in t(X;11) in infant acute myeloid leukaemia, and MLL genomic breakpoint in complex MLL-SEPTIN6 rearrangement is a DNA topoisomMLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia.Genetic lesions and perturbation of chromatin architecture: a road to cell transformation.Common themes in the pathogenesis of acute myeloid leukemia.Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins.Adenovirus E1A: remodelling the host cell, a life or death experience.Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammationFlt3 does not play a critical role in murine myeloid leukemias induced by MLL fusion genes.Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia.The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases.MLL fusions: pathways to leukemia
P2860
Q21144471-0DE4BDED-13DE-4D82-9CB6-7861E24C27B4Q24291407-FEFEB72D-FFE3-4008-A746-6A509F648D7FQ24294814-EE17AD73-B266-46E7-94C8-95BED213932FQ24299122-7755028A-BF17-4E82-B93F-676D4AF681CFQ24336625-8ECF1867-14D7-4A01-83A2-7A6E55125340Q24536056-340B8135-8196-42A9-861E-FD5BDC713840Q24540167-9FEFA47A-6F66-4544-A3A7-EF89BD3DC0D2Q24550876-F0CE8929-7354-49BE-BBC9-7A01A86BB9D5Q24603527-B2EAB082-2BA8-4319-A138-AB8B92D9D1A9Q24630336-DB43B4CE-0D3B-409A-A6A7-CCD8206FEF51Q24646499-772163D5-9FC6-464F-9C3D-CA2304A30CBAQ24679773-83CD2EE8-BAA5-47B9-B406-39B179A4EC20Q26829976-10DBEE3F-4B59-41F8-99E8-74911F99C5BEQ27026520-40585701-CF9A-49DC-8E4B-D76C3EBCDF08Q27658663-C77B8473-B430-4374-86CA-C0D6CB588702Q28269301-A5E4F4B3-22C3-42C9-88A0-DE5DFB03EAA3Q28269627-1C2459A5-A6AC-40C4-8719-373B12916EF2Q30167808-2052CFC7-44BA-433A-BC92-877B168A5033Q30303155-DD5B5364-7845-4F73-98F8-8BD0E07D9252Q33396101-AF105F56-C040-421F-9DAE-C29EECA6338CQ33514873-E7AD62DE-5B37-49F8-9536-3DD9227BCA2BQ33642188-662CD3F7-5B4F-4853-8D2E-4505E5D4F99FQ33673921-CDB0061D-1971-49F7-B8FA-42DA3F5C7910Q33761368-B0D54248-17B2-459C-BB75-16303EAE607CQ33997220-B2B48498-F153-4369-BC8D-8B0A1138D78EQ34035076-758C9171-F8F8-483E-996D-2C4148DE81BBQ34037337-539A9E6E-AA07-407E-9F5E-0B964A29F6BFQ34064832-540FB06C-66E2-4A1A-851C-EFAFFCFA0C29Q34080062-B7BA5D79-6F49-4F5F-A030-2D217E61675AQ34136814-D841D5B2-59D6-48C8-AAB6-49DA42F7699AQ34137337-D9A2704B-DC47-4638-BBBD-1149D8080CD9Q34349653-4569EC42-95C9-4F7F-9168-5F32B06FC7E4Q34405458-99F71807-EFC7-4A31-BE79-790E7669F678Q34405465-04F16637-487E-4CF1-99A3-6B91222DA51FQ34468761-F8DEDEA0-A8FB-4FF1-952B-25D5D360904FQ34513460-2F2D2FFD-A45D-4B2E-816B-044F61E1236DQ34973744-5F8A1796-30F5-49A8-9148-5C274B066179Q35018755-E3291508-96CE-4B0E-A293-2670D99843FCQ35666251-9D2C0C80-948E-4F96-B1D8-CC89DFE05D8AQ35788362-ACFA88F1-276A-40DE-B936-7C5F36EA7882
P2860
Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Chromatin-related properties o ...... evolves into myeloid leukemia
@ast
Chromatin-related properties o ...... evolves into myeloid leukemia
@en
Chromatin-related properties o ...... evolves into myeloid leukemia
@nl
type
label
Chromatin-related properties o ...... evolves into myeloid leukemia
@ast
Chromatin-related properties o ...... evolves into myeloid leukemia
@en
Chromatin-related properties o ...... evolves into myeloid leukemia
@nl
prefLabel
Chromatin-related properties o ...... evolves into myeloid leukemia
@ast
Chromatin-related properties o ...... evolves into myeloid leukemia
@en
Chromatin-related properties o ...... evolves into myeloid leukemia
@nl
P2093
P2860
P356
P1433
P1476
Chromatin-related properties o ...... evolves into myeloid leukemia
@en
P2093
P2860
P304
P356
10.1093/EMBOJ/19.17.4655
P407
P577
2000-09-01T00:00:00Z